Current status and future directions of cancer immunotherapy

In the past decades, our knowledge about the relationship between cancer and the immune system has increased considerably. Recent years' success of cancer immunotherapy including monoclonal antibodies (mAbs), cancer vaccines, adoptive cancer therapy and the immune checkpoint therapy has revolut...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongming, Chen, Jibei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968765/
https://www.ncbi.nlm.nih.gov/pubmed/29805703
http://dx.doi.org/10.7150/jca.24577
_version_ 1783325838568062976
author Zhang, Hongming
Chen, Jibei
author_facet Zhang, Hongming
Chen, Jibei
author_sort Zhang, Hongming
collection PubMed
description In the past decades, our knowledge about the relationship between cancer and the immune system has increased considerably. Recent years' success of cancer immunotherapy including monoclonal antibodies (mAbs), cancer vaccines, adoptive cancer therapy and the immune checkpoint therapy has revolutionized traditional cancer treatment. However, challenges still exist in this field. Personalized combination therapies via new techniques will be the next promising strategies for the future cancer treatment direction.
format Online
Article
Text
id pubmed-5968765
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-59687652018-05-25 Current status and future directions of cancer immunotherapy Zhang, Hongming Chen, Jibei J Cancer Review In the past decades, our knowledge about the relationship between cancer and the immune system has increased considerably. Recent years' success of cancer immunotherapy including monoclonal antibodies (mAbs), cancer vaccines, adoptive cancer therapy and the immune checkpoint therapy has revolutionized traditional cancer treatment. However, challenges still exist in this field. Personalized combination therapies via new techniques will be the next promising strategies for the future cancer treatment direction. Ivyspring International Publisher 2018-04-19 /pmc/articles/PMC5968765/ /pubmed/29805703 http://dx.doi.org/10.7150/jca.24577 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Review
Zhang, Hongming
Chen, Jibei
Current status and future directions of cancer immunotherapy
title Current status and future directions of cancer immunotherapy
title_full Current status and future directions of cancer immunotherapy
title_fullStr Current status and future directions of cancer immunotherapy
title_full_unstemmed Current status and future directions of cancer immunotherapy
title_short Current status and future directions of cancer immunotherapy
title_sort current status and future directions of cancer immunotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968765/
https://www.ncbi.nlm.nih.gov/pubmed/29805703
http://dx.doi.org/10.7150/jca.24577
work_keys_str_mv AT zhanghongming currentstatusandfuturedirectionsofcancerimmunotherapy
AT chenjibei currentstatusandfuturedirectionsofcancerimmunotherapy

Ejemplares similares